289 related articles for article (PubMed ID: 28373767)
1. Expression of CRM1 and CDK5 shows high prognostic accuracy for gastric cancer.
Sun YQ; Xie JW; Xie HT; Chen PC; Zhang XL; Zheng CH; Li P; Wang JB; Lin JX; Cao LL; Huang CM; Lin Y
World J Gastroenterol; 2017 Mar; 23(11):2012-2022. PubMed ID: 28373767
[TBL] [Abstract][Full Text] [Related]
2. Both high expression of nucleophosmin/B23 and CRM1 predicts poorer prognosis in human gastric cancer.
Zhou F; Chen E; You D; Song Y; Sun Z; Yue L
APMIS; 2016 Dec; 124(12):1046-1053. PubMed ID: 27714846
[TBL] [Abstract][Full Text] [Related]
3. Expression of pyruvate dehydrogenase is an independent prognostic marker in gastric cancer.
Sun XR; Sun Z; Zhu Z; Guan HX; Li CY; Zhang JY; Zhang YN; Zhou H; Zhang HJ; Xu HM; Sun MJ
World J Gastroenterol; 2015 May; 21(17):5336-44. PubMed ID: 25954108
[TBL] [Abstract][Full Text] [Related]
4. Low CA II expression is associated with tumor aggressiveness and poor prognosis in gastric cancer patients.
Hu X; Huang Z; Liao Z; He C; Fang X
Int J Clin Exp Pathol; 2014; 7(10):6716-24. PubMed ID: 25400751
[TBL] [Abstract][Full Text] [Related]
5. Low expression of CDK5RAP3 and DDRGK1 indicates a poor prognosis in patients with gastric cancer.
Lin JX; Xie XS; Weng XF; Zheng CH; Xie JW; Wang JB; Lu J; Chen QY; Cao LL; Lin M; Tu RH; Li P; Huang CM
World J Gastroenterol; 2018 Sep; 24(34):3898-3907. PubMed ID: 30228783
[TBL] [Abstract][Full Text] [Related]
6. Protein expression of HER2, 3, 4 in gastric cancer: correlation with clinical features and survival.
He XX; Ding L; Lin Y; Shu M; Wen JM; Xue L
J Clin Pathol; 2015 May; 68(5):374-80. PubMed ID: 25731189
[TBL] [Abstract][Full Text] [Related]
7. Serum fibrinogen levels are positively correlated with advanced tumor stage and poor survival in patients with gastric cancer undergoing gastrectomy: a large cohort retrospective study.
Yu X; Hu F; Yao Q; Li C; Zhang H; Xue Y
BMC Cancer; 2016 Jul; 16():480. PubMed ID: 27418164
[TBL] [Abstract][Full Text] [Related]
8. The significance of NTR1 expression and its correlation with β-catenin and EGFR in gastric cancer.
Zhou Z; Xie J; Cai Y; Yang S; Chen Y; Wu H
Diagn Pathol; 2015 Jul; 10():128. PubMed ID: 26215716
[TBL] [Abstract][Full Text] [Related]
9. Prognostic importance of RASSF2 expression in patients with gastric cancer who had undergone radical gastrectomy.
Aydin D; Bilici A; Kayahan S; Yavuzer D; Basar M; Aliustaoglu M
Clin Transl Oncol; 2016 Jun; 18(6):608-16. PubMed ID: 26459248
[TBL] [Abstract][Full Text] [Related]
10. The log odds of negative lymph nodes/T stage: a new prognostic and predictive tool for resected gastric cancer patients.
Xie J; Pang Y; Li X; Wu X
J Cancer Res Clin Oncol; 2021 Aug; 147(8):2259-2269. PubMed ID: 34003367
[TBL] [Abstract][Full Text] [Related]
11. Relationship between expression of IGFBP7 and clinicopathological variables in gastric cancer.
Sato Y; Inokuchi M; Takagi Y; Otsuki S; Fujimori Y; Yanaka Y; Kobayashi K; Higuchi K; Kojima K; Kawano T
J Clin Pathol; 2015 Oct; 68(10):795-801. PubMed ID: 26043748
[TBL] [Abstract][Full Text] [Related]
12. High expression of C-C chemokine receptor 2 associates with poor overall survival in gastric cancer patients after surgical resection.
Li R; Zhang H; Liu H; Lin C; Cao Y; Zhang W; Shen Z; Xu J
Oncotarget; 2016 Apr; 7(17):23909-18. PubMed ID: 26992207
[TBL] [Abstract][Full Text] [Related]
13. An immunohistochemical study of cyclin-dependent kinase 5 (CDK5) expression in non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC): a possible prognostic biomarker.
Wei K; Ye Z; Li Z; Dang Y; Chen X; Huang N; Bao C; Gan T; Yang L; Chen G
World J Surg Oncol; 2016 Feb; 14(1):34. PubMed ID: 26860827
[TBL] [Abstract][Full Text] [Related]
14. Lymph node ratio is an independent prognostic factor in gastric cancer after curative resection (R0) regardless of the examined number of lymph nodes.
Alatengbaolide ; Lin D; Li Y; Xu H; Chen J; Wang B; Liu C; Lu P
Am J Clin Oncol; 2013 Aug; 36(4):325-30. PubMed ID: 22547011
[TBL] [Abstract][Full Text] [Related]
15. Adenocarcinoma in the middle third of the stomach--an evaluation for the prognostic significance of clinicopathological features.
Sheen-Chen SM; Chou CW; Chen MC; Chen FC; Chen YS; Chen JJ
Hepatogastroenterology; 1997; 44(17):1488-94. PubMed ID: 9356878
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of metastatic lymph nodes ratio in patients with gastric adenocarcinoma after curative gastrectomy.
Zhang M; Wang J; Shi W; Chen W; Li W; Shu Y; Liu P; Lu K
Chin Med J (Engl); 2014; 127(10):1874-8. PubMed ID: 24824248
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of mixed lineage kinase domain-like protein expression in the survival of patients with gastric caner.
Ertao Z; Jianhui C; Kang W; Zhijun Y; Hui W; Chuangqi C; Changjiang Q; Sile C; Yulong H; Shirong C
Tumour Biol; 2016 Oct; 37(10):13679-13685. PubMed ID: 27473085
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathological Variation of Lauren Classification in Gastric Cancer.
Chen YC; Fang WL; Wang RF; Liu CA; Yang MH; Lo SS; Wu CW; Li AF; Shyr YM; Huang KH
Pathol Oncol Res; 2016 Jan; 22(1):197-202. PubMed ID: 26502923
[TBL] [Abstract][Full Text] [Related]
19. Increased expression of DLX2 correlates with advanced stage of gastric adenocarcinoma.
Tang P; Huang H; Chang J; Zhao GF; Lu ML; Wang Y
World J Gastroenterol; 2013 May; 19(17):2697-703. PubMed ID: 23674878
[TBL] [Abstract][Full Text] [Related]
20. ARID1A expression in gastric adenocarcinoma: clinicopathological significance and correlation with DNA mismatch repair status.
Inada R; Sekine S; Taniguchi H; Tsuda H; Katai H; Fujiwara T; Kushima R
World J Gastroenterol; 2015 Feb; 21(7):2159-68. PubMed ID: 25717252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
